Novo Nordisk A S

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC NVO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

22,809

Value ($000)

1,161

Weight

0.0%

2022 Q1 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,161	0.0%	22,809	12/31/2025
2025 Q3	11/13/2025	1,874	0.0%	33,773	9/30/2025
2025 Q2	8/13/2025	1,592	0.0%	23,068	6/30/2025
2025 Q1	5/14/2025	1,691	0.0%	24,346	3/31/2025
2024 Q4	2/21/2025	2,217	0.0%	25,773	12/31/2024
2024 Q3	11/13/2024	3,175	0.0%	26,667	9/30/2024
2024 Q2	8/13/2024	5,226	0.0%	36,608	6/30/2024
2024 Q1	5/14/2024	5,677	0.0%	44,214	3/31/2024
2023 Q4	2/13/2024	5,323	0.0%	51,455	12/31/2023
2023 Q3	11/13/2023	4,337	0.0%	47,686	9/30/2023
2023 Q2	8/11/2023	4,275	0.0%	26,417	6/30/2023
2023 Q1	5/16/2023	4,005	0.0%	25,164	3/31/2023
2022 Q4	2/14/2023	2,796	0.0%	20,659	12/31/2022
2022 Q3	11/16/2022	1,686	0.0%	16,922	9/30/2022
2022 Q1	5/16/2022	5	0.0%	45	3/31/2022